Thompson-Peach, C. A. L., Thomas, D., Dottore, M., Lim, K., Stomski, F., Panagopoulos, R. A., Foßelteder, J., Reinisch, A., Chandrakanthan, V., Jenkner, S., Bland, L., Paton, S., Gronthos, S., Hercus, T. R., Wardill, H. R., Kan, W. L., Kamel, M. M., Moretti, P. A., Pitson, S. M., Burbury, K., Ross, D. M., Nair, P. C., Lopez, A. F., Tvorogov, D. (2026). Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity. Blood. https://doi.org/10.1182/blood.2024027897